Digital therapeutics and virtual care provider Biofourmis surpassed a $1 billion valuation when it closed a $300 million series D funding round April 26.
Read the full post on Becker's Hospital Review - Healthcare News
Biofourmis reaches unicorn status, welcomes former Medtronic CEO
